ArticleFrontiers in oncology2021
Overall Survival Prediction for Gliomas Using a Novel Compound Approach.
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Individualized Treatment Effect Inference of Head and Neck Cancer with Multimodal Data.APSIPA Transactions on Signal and Information Processing · 2026Article
- Machine learning integration of multi-modal radiomics and clinical factors predicts refracture risk after percutaneous kyphoplasty in postmenopausal women.Scientific reports · 2025Article
- Advanced Deep Learning and Machine Learning Techniques for MRI Brain Tumor Analysis: A Review.Sensors (Basel, Switzerland) · 2025Review
- Multimodal deep learning improves recurrence risk prediction in pediatric low-grade gliomas.Neuro-oncology · 2025Article
- A comprehensive evaluation of MRI-based radiogenomics and prognosis prediction in glioma.Frontiers in oncology · 2025Article
- End-to-End Multi-task Learning Architecture for Brain Tumor Analysis with Uncertainty Estimation in MRI Images.Journal of imaging informatics in medicine · 2024Article
- Treatment-wise Glioblastoma Survival Inference with Multi-parametric Preoperative MRI.Proceedings of SPIE--the International Society for Optical Engineering · 2024Article
- Brain tumour genetic network signatures of survival.Brain : a journal of neurology · 2023Article
- Non-invasive prediction of overall survival time for glioblastoma multiforme patients based on multimodal MRI radiomics.International journal of imaging systems and technology · 2023Article
- Predicting Survival in Patients with Brain Tumors: Current State-of-the-Art of AI Methods Applied to MRI.Diagnostics (Basel, Switzerland) · 2022Review
- A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas.Journal of clinical medicine · 2022Review
- The Circ_0001367/miR-545-3p/LUZP1 Axis Regulates Cell Proliferation, Migration and Invasion in Glioma Cells.Frontiers in oncology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As a highly malignant tumor, the incidence and mortality of glioma are not optimistic. Predicting the survival time of patients with glioma by extracting the feature information from gliomas is beneficial for doctors to develop more targeted treatments. Magnetic resonance imaging (MRI) is a way to quickly and clearly capture the details of brain tissue. However, manually segmenting brain tumors from MRI will cost doctors a lot of energy, and doctors can only vaguely estimate the survival time of glioma patients, which are not conducive to the formulation of treatment plans. Therefore, automatically segmenting brain tumors and accurately predicting survival time has important significance. In this article, we first propose the NLSE-VNet model, which integrates the Non-Local module and the Squeeze-and-Excitation module into V-Net to segment three brain tumor sub-regions in multimodal MRI. Then extract the intensity, texture, wavelet, shape and other radiological features from the tumor area, and use the CNN network to extract the deep features. The factor analysis method is used to reduce the dimensionality of features, and finally the dimensionality-reduced features and clinical features such as age and tumor grade are combined into the random forest regression model to predict survival. We evaluate the effect on the BraTS 2019 and BraTS 2020 datasets. The average Dice of brain tumor segmentation tasks up to 79% and the average RMSE of the survival predictive task is as low as 311.5. The results indicate that the method in this paper has great advantages in segmentation and survival prediction of gliomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.